KalVista Pharmaceuticals (KALV) Treasury Shares (2014 - 2025)
KalVista Pharmaceuticals (KALV) reported Treasury Shares of $2.6 million for Q2 2025, up 316.88% on a YoY basis from $626272.0 in Q2 2024, and up 316.88% sequentially from $626272.0 in Q2 2024.
KalVista Pharmaceuticals (KALV) Treasury Shares (2014 - 2025) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 6 years of Treasury Shares data on file, last reported at $2.6 million in Q2 2025.
- For the quarter ending Q2 2025, Treasury Shares rose 316.88% year-over-year to $2.6 million; the trailing twelve-month figure through Apr 2025 stood at $2.6 million (up 316.88% YoY), and the FY2025 full-year result was $2.6 million, up 316.88% from the prior year.
- Treasury Shares grew to $2.6 million in Q2 2025, from $626272.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.6 million in Q2 2025 to a low of $626272.0 in Q2 2024.
- A 3-year average of $1.3 million and a median of $742242.0 in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares slipped 15.62% in 2024 and jumped 316.88% in 2025, its largest moves.
- Tracing KALV's Treasury Shares over 3 years: stood at $742242.0 in 2023, then decreased by 15.62% to $626272.0 in 2024, then jumped by 316.88% to $2.6 million in 2025.
- Business Quant data shows KALV's Treasury Shares at $2.6 million in Q2 2025, $626272.0 in Q2 2024, and $742242.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 2.61 Mn |
| Apr 30, 2025 | 2.61 Mn |
| Apr 30, 2024 | 626,272.00 |
| Apr 30, 2024 | 626,272.00 |
| Apr 30, 2023 | 742,242.00 |
| Apr 30, 2023 | 742,242.00 |
| Apr 30, 2020 | 45,000.00 |
| Apr 30, 2020 | 45,000.00 |
| Mar 31, 2015 | 8.27 Mn |
| Mar 31, 2015 | 8.27 Mn |
| Dec 31, 2014 | 8.27 Mn |
| Dec 31, 2014 | 8.27 Mn |